Literature DB >> 30370949

Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry.

Jong Wook Lee1, Régis Peffault de Latour2,3, Robert A Brodsky4, Jun Ho Jang5, Anita Hill6, Alexander Röth7, Hubert Schrezenmeier8, Amanda Wilson9, Jing L Marantz9, Jaroslaw P Maciejewski10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30370949     DOI： 10.1002/ajh.25334

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  8 in total

1.  Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.

Authors:  Deniz Goren Sahin; Olga Meltem Akay; Muzaffer Keklik; Vahap Okan; Abdullah Karakus; Cengiz Demir; Mehmet Ali Erkurt; Kadir Ilkkilic; Rahsan Yildirim; Gulsum Akgun Cagliyan; Salih Aksu; Mehmet Hilmi Dogu; Mehmet Sinan Dal; Volkan Karakus; Ali Ihsan Gemici; Hatice Terzi; Engin Kelkitli; Serdar Sivgin; Ali Unal; Mehmet Yilmaz; Orhan Ayyildiz; Serdal Korkmaz; Bulent Eser; Fevzi Altuntas
Journal:  Ann Hematol       Date:  2021-05-14       Impact factor: 3.673

2.  Significance of paroxysmal nocturnal hemoglobinuria clone in immunosuppressive therapy for children with severe aplastic anemia.

Authors:  Jun Li; Su-Yu Zong; Zi-Xi Yin; Yang-Yang Gao; Li-Peng Liu; Yang Wan; Yang Lan; Xiao-Wen Gong; Xiao-Fan Zhu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-03-15

3.  Evaluation of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in Turkey: a multicenter retrospective analysis.

Authors:  Fatma Keklik Karadag; Mustafa Nuri Yenerel; Mehmet Yılmaz; Hava Uskudar; Vildan Ozkocaman; Tülin Firatli Tuglular; Fuat Erdem; Ali Unal; Orhan Ayyildiz; Gülsüm Ozet; Melda Comert; Emin Kaya; Mesut Ayer; Ozan Salim; Birol Guvenc; Hakan Ozdogu; Özgur Mehtap; Mehmet Sonmez; Nil Guler; Sibel Hacioglu; İsmet Aydogdu; Ozlen Bektas; Selami Kocak Toprak; Lale Kaynar; Munci Yagci; Salih Aksu; Anil Tombak; Volkan Karakus; İrfan Yavasoglu; Birgul Onec; Mehmet Ali Ozcan; Levent Undar; Rıdvan Ali; Osman Ilhan; Guray Saydam; Fahri Sahin
Journal:  Am J Blood Res       Date:  2021-06-15

4.  Markers of Thrombin Generation and Inflammation in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Rishi Dhawan; Jasmina Ahluwalia; Pankaj Malhotra; Manoranjan Mahapatra; Neelam Varma; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2019-11-26       Impact factor: 0.900

5.  Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change.

Authors:  Eleni Gavriilaki; Ioanna Sakellari; Despina Mallouri; Ioannis Batsis; Thomas Chatziconstantinou; Anna Vardi; Zoi Bousiou; Marianna Masmanidou; Vassiliki Douka; Antonia Syrigou; Damianos Sotiropoulos; Varnavas Constantinou; Achilles Anagnostopoulos
Journal:  Hemasphere       Date:  2020-04-01

6.  The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies.

Authors:  Coralina Bernuy-Guevara; Hassib Chehade; Yannick D Muller; Julien Vionnet; François Cachat; Gabriella Guzzo; Carlos Ochoa-Sangrador; F Javier Álvarez; Daniel Teta; Débora Martín-García; Marcel Adler; Félix J de Paz; Frank Lizaraso-Soto; Manuel Pascual; Francisco Herrera-Gómez
Journal:  Biomedicines       Date:  2020-09-16

Review 7.  Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry.

Authors:  Margarida Lima
Journal:  Pract Lab Med       Date:  2020-03-10

Review 8.  How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.

Authors:  Antonio Maria Risitano; Régis Peffault de Latour
Journal:  Br J Haematol       Date:  2021-08-05       Impact factor: 8.615
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.